All In Biotech

Free tool

FAERS Monitor: Cimzia

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 125160 or its brand name (Cimzia, Certolizumab Pegol). Reports on generic versions are filed under their own applications.

Reports

119,210

Serious

76,429

64% of reports

Hospitalization

21,861

Death reported

6,869

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective27,487
  • rheumatoid arthritis20,222
  • pain16,271
  • fatigue13,878
  • off label use11,976
  • rash11,259
  • arthralgia11,196
  • alopecia10,275
  • maternal exposure during pregnancy9,987
  • joint swelling9,984
  • abdominal discomfort9,709
  • systemic lupus erythematosus9,289
  • swelling8,877
  • pemphigus8,861
  • drug intolerance8,813

Reports by year received

View as table
YearReports
20061
20073
200829
20092,235
20103,589
20113,495
20121,594
20131,751
20141,658
20152,889
20165,758
20174,121
20185,052
201912,587
202010,671
202110,545
202211,785
202310,486
202412,714
202512,095
20266,151

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,934,949 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pemphigusSignal8,861426.0410.11,097,226
systemic lupus erythematosusSignal9,28962.260.8413,537
rheumatoid arthritisSignal20,22238.037.5602,323
maternal exposure during pregnancySignal9,98722.121.7179,737
swellingSignal8,87718.418.0132,657
drug intoleranceSignal8,81317.617.2126,051
joint swellingSignal9,98415.815.5127,854
abdominal discomfortSignal9,70910.810.681,781
alopeciaSignal10,2759.79.576,551
arthralgiaSignal11,1964.94.834,014
painSignal16,2714.84.748,667
rashSignal11,2594.74.632,102
drug ineffectiveSignal27,4873.73.757,551
fatigueSignal13,8783.23.121,202
off label useSignal11,9762.42.410,398

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.